5-Chloro-N2-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine

Catalog No. :
ACPIXJ821
CAS No. :
1032900-26-7
Molecular Formula :
C29H38ClN5O3S
Molecular Weight :
572.17

IUPAC Name:5-chloro-N2-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine

5-Chloro-N2-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-N2-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine
IUPAC Name5-chloro-N2-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine
Molecular FormulaC29H38ClN5O3S
Molecular Weight572.17
SMILESO=S(C1=CC=CC=C1NC2=NC(NC3=CC(C)=C(C4CCN(C)CC4)C=C3OC(C)C)=NC=C2Cl)(C(C)C)=O
InChI KeyNBMMGFKSCSDKBQ-UHFFFAOYSA-N
Synonym2,4-Pyrimidinediamine, 5-chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(1-methyl-4-piperidinyl)phenyl]-
CAS No.1032900-26-7

Synthetic Route by SureRoute

1. ACPIXJ821 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRUHS063 route compound structure diagram
    ACRUHS0631380575-43-8 In Stock
  4. Then
  5. ACPIXJ821 route product structure diagram
    ACPIXJ8211032900-26-7
Inquiry

2. ACPIXJ821 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPIXJ821 route product structure diagram
    ACPIXJ8211032900-26-7
Inquiry

Comments (0)